ApoGen Biotechnologies

ApoGen Biotechnologies

ApoGen Biotechnologies

As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constantnearly all cancer drug therapies eventually fail due to the development of dru
Founded
2014
Raised
$11M
Follow us
Alexa global traffic share
Latest funding
$4,000,000
Venture capital (Series A) - 2018
M Ventures
$7,000,000
Venture capital (Series A) - 2016
Alexandria Venture ARCH Venture Partners WRF Capital +6
Team Size
2
Employees
$4,000,000 Venture capital (Series A)
FinSMEs , MedCity News , PE HUB , +1

ApoGen Biotechnologies Raises $4m in Series A Funding

Funding Health Science
$7,000,000 Venture capital (Series A)
FinSMEs , Xconomy , businesswire , +1

ApoGen Biotechnologies Raises $7M in Series A Funding